Select Medical (NYSE:SEM) Reaches New 52-Week Low – Here’s What Happened

Select Medical Holdings Co. (NYSE:SEM)’s share price reached a new 52-week low during trading on Wednesday . The stock traded as low as $19.92 and last traded at $19.92, with a volume of 114232 shares traded. The stock had previously closed at $20.57.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on SEM. Royal Bank of Canada upped their price target on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Bank of America assumed coverage on Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th.

Select Medical Stock Down 1.4 %

The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The firm has a market capitalization of $2.63 billion, a price-to-earnings ratio of 9.62, a P/E/G ratio of 0.47 and a beta of 1.43. The firm has a fifty day moving average price of $33.53 and a 200 day moving average price of $34.53.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the company earned $0.46 EPS. Sell-side analysts anticipate that Select Medical Holdings Co. will post 1.74 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s payout ratio is presently 23.36%.

Insiders Place Their Bets

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now owns 22,000 shares of the company’s stock, valued at $463,980. This trade represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 17.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its holdings in Select Medical by 2.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after acquiring an additional 95,578 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after buying an additional 46,880 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after acquiring an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. raised its position in Select Medical by 144.2% during the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Select Medical by 1.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after purchasing an additional 24,439 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.